4//SEC Filing
LIDGARD GRAHAM PETER 4
Accession 0001209191-21-020475
CIK 0001124140other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:37 PM ET
Size
14.6 KB
Accession
0001209191-21-020475
Insider Transaction Report
Form 4
LIDGARD GRAHAM PETER
SVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2021-03-11$21.68/sh+34,891$756,437→ 73,258 total - Exercise/Conversion
Common Stock
2021-03-11$44.37/sh+8,350$370,490→ 81,608 total - Sale
Common Stock
2021-03-11$130.00/sh−43,241$5,621,330→ 38,367 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-11−34,891→ 0 totalExercise: $21.68→ Common Stock (34,891 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-03-11−8,350→ 4,175 totalExercise: $44.37→ Common Stock (8,350 underlying)
Holdings
- 12,846(indirect: By 401(k))
Common Stock
- 4,673(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Represents shares of common stock received upon exercise of a stock option award.
- [F2]The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]In addition to the shares of Common Stock reported on this Form 4, which total 55,886 shares, Mr. Lidgard also holds, in the aggregate, an additional 63,752 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
- [F4]These options vested and became exercisable in four equal annual installments beginning on February 23, 2018.
- [F5]These options vest and become exercisable in four equal annual installments beginning on February 27, 2019.
Documents
Issuer
EXACT SCIENCES CORP
CIK 0001124140
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001216274
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:37 PM ET
- Size
- 14.6 KB